BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9815758)

  • 1. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens.
    Wilcken NR; Prall OW; Musgrove EA; Sutherland RL
    Clin Cancer Res; 1997 Jun; 3(6):849-54. PubMed ID: 9815758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
    Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
    Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
    Watts CK; Sweeney KJ; Warlters A; Musgrove EA; Sutherland RL
    Breast Cancer Res Treat; 1994; 31(1):95-105. PubMed ID: 7981461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells.
    Wilcken NR; Sarcevic B; Musgrove EA; Sutherland RL
    Cell Growth Differ; 1996 Jan; 7(1):65-74. PubMed ID: 8788034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells.
    Foster JS; Wimalasena J
    Mol Endocrinol; 1996 May; 10(5):488-98. PubMed ID: 8732680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA; Sarcevic B; Sutherland RL
    J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.
    Prall OW; Rogan EM; Musgrove EA; Watts CK; Sutherland RL
    Mol Cell Biol; 1998 Aug; 18(8):4499-508. PubMed ID: 9671459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.
    Carlson B; Lahusen T; Singh S; Loaiza-Perez A; Worland PJ; Pestell R; Albanese C; Sausville EA; Senderowicz AM
    Cancer Res; 1999 Sep; 59(18):4634-41. PubMed ID: 10493518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens.
    Pacilio C; Germano D; Addeo R; Altucci L; Petrizzi VB; Cancemi M; Cicatiello L; Salzano S; Lallemand F; Michalides RJ; Bresciani F; Weisz A
    Cancer Res; 1998 Mar; 58(5):871-6. PubMed ID: 9500441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.
    Musgrove EA; Hamilton JA; Lee CS; Sweeney KJ; Watts CK; Sutherland RL
    Mol Cell Biol; 1993 Jun; 13(6):3577-87. PubMed ID: 8497271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells.
    Kilker RL; Hartl MW; Rutherford TM; Planas-Silva MD
    J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):63-71. PubMed ID: 15544931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of estradiol and its analogs on cyclin D1 and CDK4 expression in estrogen receptor positive MCF-7 and estrogen receptor-transfected MCF-10AEwt5 cells.
    Hong J; Shah NN; Thomas TJ; Gallo MA; Yurkow EJ; Thomas T
    Oncol Rep; 1998; 5(5):1025-33. PubMed ID: 9683804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    BrĂ¼nner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
    Herman ME; Katzenellenbogen BS
    J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
    Musgrove EA; Wakeling AE; Sutherland RL
    Cancer Res; 1989 May; 49(9):2398-404. PubMed ID: 2706627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.
    Musgrove EA; Lee CS; Cornish AL; Swarbrick A; Sutherland RL
    Mol Endocrinol; 1997 Jan; 11(1):54-66. PubMed ID: 8994188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.